Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Yes wild, the manipulation on the OTC market by NITE and CANT aside, Rxi's sd-rxRNA technology is amazing as a "self delivering" RNAi. I mean I don't understand why people are not impressed, you have the only company in the world to produce RNAi oligonucleotides with no delivery vehicle required.

Alnylam, Tekmira, Arrowhead, silence etc. all require a delivery method which takes away from the efficacy. This is because all those companies have to encapsulate the RNAi oligonucleotide into a lipid/nanoparticle to deliver it into cells. Rxi requires nothing but the RNAi strand itself.

Look at what Rxi is targeting after RXI-109 for scarring. They are going after Regeneron's market with macular degeneration, diabetic eye disease, PVR, Retinoblastoma. This company is a long term keeper!